Hasan M. Rizvi
Kettering, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
CT-guided lung biopsy service with conservative management of pneumothorax.
Journal: Future healthcare journal
Published: March 12, 2025
Enhanced metastasis risk prediction in cutaneous squamous cell carcinoma using deep learning and computational histopathology.
Journal: NPJ precision oncology
Published: February 19, 2025
Extensive Bone Marrow Involvement by BRAF V660E-Mutated Bi-Phenotypic Erdheim-Chester Neoplasm/Rosai-Dorfman Disease (Mixed Histiocytic Neoplasm) with Atypical Histological Features and Fulminant Hemophagocytosis.
Journal: Case reports in oncology
Published: February 05, 2025
A CD24+CD271+ melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistance.
Journal: BMC biology
Published: October 02, 2024
Applications of machine and deep learning to thyroid cytology and histopathology: a review.
Journal: Frontiers in oncology
Published: May 31, 2022
Application of Tourniquet Does Not Influence Early Clinical Outcomes After Total Knee Arthroplasty.
Journal: Cureus
Published: February 08, 2021
Radiologically guided percutaneous core needle biopsy of the spleen: a reliable and safe diagnostic procedure for neoplastic and reactive conditions.
Journal: Histopathology
Published: November 10, 2020
Association of Pulmonary Hypertension With End-Stage Renal Disease Among the Obese Population.
Journal: Cureus
Published: September 18, 2020
Echocardiographic Changes in Chronic Kidney Disease Patients on Maintenance Hemodialysis.
Journal: Cureus
Published: August 09, 2020
Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program.
Journal: Infectious agents and cancer
Published: June 13, 2020
Development of a Validated Exam to Assess Pathologist Knowledge of Genomic Oncology.
Journal: Archives of pathology & laboratory medicine
Published: June 01, 2020
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
Journal: Lancet (London, England)
Published: April 05, 2020
Last Updated: 09/26/2026